Myriad Genetics, Inc.MYGNNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank43
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.57
↓ 104% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
42.25
Historical baseline
PeriodValueYoY Change
2025-1.57+83.9%
2024-9.76-62.1%
2023-6.02+42.3%
2022-10.44+86.8%
2021-78.86-1094.5%
2020-6.60-56.3%
2019-4.22-101.0%
2018439.24+2118.7%
201719.80-75.5%
201680.96-